Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis

John Boletis; John P A Ioannidis; Kyriaki Boki; Haralampos Μ. Moutsopoulos

doi:10.1016/s0140-6736(99)01575-5

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2000

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide

John P A Ioannidis, Kyriaki Boki, Maria E. Katsorida, Alexandros A. Drosos, Fotini N. Skopouli, John Boletis, Haralampos M. Moutsopoulos

Article2014

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

Rosanna Coppo, Licia Peruzzi, Alessandro Amore, Silvana Martino, Luca Vergano, Inna Lastauka, Arrigo Schieppati, Marina Noris, Pier‐Angelo Tovo, Giuseppe Remuzzi

Article2002

Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus.

John P A Ioannidis, Gikas Katsifis, Athanasios G. Tzioufas, Haralampos Μ. Moutsopoulos

Article2011

Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis

Alessandro Blè, Marta Mosca, Giorgio Di Loreto, Angelo Guglielmotti, Giuseppe Biondi, Stefano Bombardieri, Giuseppe Remuzzi, Piero Ruggenenti

Dataset

Supplementary Material for: Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis

Alessandro Blè, Marta Mosca, Giorgio Di Loreto, Angelo Guglielmotti, Giuseppe Biondi, Stefano Bombardieri, Giuseppe Remuzzi, Piero Ruggenenti